Table 1.
Baseline patient characteristics for patients with AKI and non-AKI on presentation with new Gram-negative bacteraemia
| Non-AKI | AKI | P value | |
|---|---|---|---|
| No. of patients | 412 | 235 | — |
| Age, years, median (range) | 69 (18–100) | 78 (25–98) | <0.001 |
| Sex, male, n (%) | 197 (47.8) | 127 (54) | 0.141 |
| Community acquired/onset episodes, n (%) | 343 (83.3) | 202 (90) | 0.432 |
| Critical care admission during episode, n (%) | 29 (7.0) | 43 (18.3) | <0.001 |
| Baseline GFR, mL/min, median (SD) | 68.5(±22.7) | 39.5(±18.1) | <0.001 |
| Pathogen | |||
| Enterobacterales, n | 369 | 222 | 0.041 |
| Gentamicin, % S | 89.7 | 84.2 | |
| Amoxicillin/clavulanate, % S | 62.1 | 62.1 | |
| 3GC, % S | 82.7 | 76.1 | |
| Carbapenem, % S | 100 | 99.5 | |
| Pseudomonas, n | 33 | 12 | 0.259 |
| Gentamicin, % S | 93.9 | 100 | |
| 3GC, % S | 100 | 100 | |
| Carbapenem, % S | 81.8 | 100 | |
| Other, n | 10a | 1b | |
S, susceptible; 3GC, third generation cephalosporins.
a
Other pathogens include Achromobacter spp. (2), Campylobacter spp. (2), Moraxella spp. (2) and Neisseria spp. (4).
b
In the AKI group a single Pasteurella sp. was isolated.